© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Collegium Pharmaceutical, Inc. (COLL) shows an Average True Range (ATR) of 1.4 and an Enterprise Value of 1.57B. Its average trading volume over the past 3 months is 457.49K, indicating liquidity. These fundamental metrics provide insight into COLL's underlying financial health and market activity.
Collegium Pharmaceutical, Inc. (COLL) technical indicators as of December 22, 2025: the SMA 20 is 2.65%, SMA 50 at 16.38%, and SMA 200 at 42.99%. The RSI 14 value is 67.26, suggesting its current momentum. These technical analysis signals help assess COLL's price trends and potential future movements.
Collegium Pharmaceutical, Inc. (COLL) stock performance overview as of December 22, 2025: The 52-week high is $49.79 (currently -2.08% below), and the 52-week low is $23.23 (currently 110.42% above). Over the past year, COLL's performance is 62.45%, compared to the S&P 500's 12.87% change.
According to market data, Collegium Pharmaceutical, Inc. (COLL) stock's recent performance metrics show that over the last month, COLL is 7.81%, with a Year-to-Date (YTD) performance of 70.61%. Over the past year, the stock has seen a 62.45% change. These figures summarize COLL's price movements across various periods, reflecting its historical returns.
According to current financial data, COLL stock's P/E (TTM) ratio is 26.41, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for COLL, including P/S (2.04), P/B (5.62), and P/FCF (5.34), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.